DelSiTech provides drug delivery services within the pharmaceutical and biotech industries, specialising in the biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals, and viral vectors. The company focuses on parenteral and local administration of drug products.

Services include:
– Biodegradable silica-based controlled release formulations
– Drug delivery services for small molecule drugs
– Delivery of biopharmaceuticals
– Viral vector development and supply
– Contract manufacturing for drug products
– Customised formulation development

DelSiTech is committed to advancing drug delivery technologies and improving therapeutic outcomes for patients. For more information, please visit delsitech.com.